Scientists have developed a single vaccine that can protect against 20 different strains of pneumonia-causing bacteria. This breakthrough could simplify immunisation, reduce healthcare costs, and boost protection in vulnerable populations. Early trials show strong immune response, raising hopes for broader, more efficient prevention against deadly respiratory infections.